Nexstim Oyj (FRA:5NX) Other Current Receivables: €0.67 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:5NX Nexstim Oyj FRA:5NX
69 GF Score
Price €9.78
GF Value €9.65
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Nexstim Oyj Other Current Receivables?

Nexstim Oyj FRA:5NX +6.07% 69 Other Current Receivables is €0.67 Mil as of Jun. 2026. GuruFocus rates FRA:5NX with a GF Score™ of 69/100 and a GF Value™ of €9.65 (Fairly Valued). The stock has 5 warning signs investors should review.

Nexstim Oyj's Other Current Receivables for the quarter that ended in Jun. 2026 was €0.67 Mil.

Nexstim Oyj's quarterly Other Current Receivables declined from Jun. 2025 (€0.92 Mil) to Dec. 2025 (€0.08 Mil) but then increased from Dec. 2025 (€0.08 Mil) to Jun. 2026 (€0.67 Mil).

Nexstim Oyj's annual Other Current Receivables declined from Dec. 2023 (€0.31 Mil) to Dec. 2024 (€0.13 Mil) and declined from Dec. 2024 (€0.13 Mil) to Dec. 2025 (€0.08 Mil).

Nexstim Oyj Other Current Receivables Related Terms

Nexstim Oyj Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Nexstim Oyj's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nexstim Oyj Other Current Receivables Chart

Nexstim Oyj Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.41 0.19 0.31 0.13 0.08

Nexstim Oyj Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.60 0.13 0.92 0.08 0.67
FRA:5NX
69GF Score
Nexstim Oyj FRA:5NX
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nexstim Oyj Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of €0.67 Mil mean?
Nexstim Oyj (FRA:5NX) has a Other Current Receivables of €0.67 Mil as of Jun. 2026. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Nexstim Oyj and its competitors.
Is Nexstim Oyj's Other Current Receivables too high?
Nexstim Oyj's current Other Current Receivables is €0.67 Mil. Overall, Nexstim Oyj has a GF Score™ of 69/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Nexstim Oyj's Other Current Receivables compare to ABT and SYK?
Nexstim Oyj's Other Current Receivables of €0.67 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Medical Devices & Instruments company?
A good Other Current Receivables depends on the Medical Devices & Instruments industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Nexstim Oyj and its competitors. Nexstim Oyj's current Other Current Receivables is €0.67 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nexstim Oyj stock overvalued right now?
Based on GuruFocus' analysis, Nexstim Oyj (FRA:5NX) is currently considered Fairly Valued. The stock's GF Value™ is €9.65, compared to a current price of €9.78 — trading 1.3% above its estimated fair value. The current Other Current Receivables is €0.67 Mil. Nexstim Oyj's overall GF Score™ is 69/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Nexstim Oyj (FRA:5NX), the current Other Current Receivables is €0.67 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nexstim Oyj (FRA:5NX) Overvalued in 2026?

Based on GuruFocus' analysis, Nexstim Oyj stock appears to be overvalued. The current stock price of €9.78 is trading 1.3% above its estimated GF Value™ of €9.65. GuruFocus considers Nexstim Oyj to be Fairly Valued.

Key valuation signals for FRA:5NX:

  • Other Current Receivables: €0.67 Mil
  • GF Value™: €9.65 vs. price of €9.78 (1.3% above fair value)
  • GF Score™: 69/100 with 5 warning signs

No single metric tells the full story. See the FRA:5NX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Nexstim Oyj Business Description

Other Exchanges NXTMH:Finland
Address Elimaenkatu 9 B, Helsinki, FIN, 00510
Nexstim Oyj is a Finnish medical technology company. It has developed a non-invasive brain-stimulation technology for navigated transcranial magnetic stimulation (nTMS), with sophisticated 3D navigation that provides accurate, personalized targeting of TMS to specific brain areas. The company's diagnostic business focuses on commercializing the NBS System 6, an FDA-cleared, CE-marked navigated TMS system for pre-surgical mapping of the brain's speech and motor cortices. Its therapy business sells the NBS System 6 for the treatment of depressive disorder in the United States, and for the treatment of depression, chronic neuropathic pain, and post-operative rehabilitation of motor deficits of the upper limb, in Europe. Geographically, the firm generates maximum revenue from North America.
69GF Score

Get the complete analysis for FRA:5NX

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€9.78
Price
€9.65
GF Value